Information for Action

Search Tenders

Pharmaceutical & Medical Information for Action

Information for Action

Information for Action has been closed on 30 May 2021. It no longer accepts any bids. For further information, you can contact the MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA

Bellow, you can find more information about this project:

Location: Moldova, Austria, Latvia, Estonia, Germany, Poland, France, Cyprus, Slovenia, Bosnia-Herzegovina and other 7 countries

General information

Donor:

MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA

HIGIENOS INSTITUTAS

UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE NICOLAE TESTEMITANU DIN REPUBLICA MOLDOVA

MINISTERE DE LA SANTE

INSTITUT ZA ZASTITU ZDRAVLJA SRBIJEDR MILAN JOVANOVIC BATUT

HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO

SOTSIAALMINISTEERIUM

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU

ETHNIKOS ORGANISMOS PAROCHIS YPIRESION YGIAS

USTAV ZDRAVOTNICKYCH INFORMACI A STATISTIKY CESKE REPUBLIKY

SLIMIBU PROFILAKSES UN KONTROLES CENTRS

MINISTRY OF CIVIL AFFAIRS

DEPARTMENT OF HEALTH

AGENCE NATIONALE DE SANTE PUBLIQUE

FOLKHALSOMYNDIGHETEN

ISTITUTO SUPERIORE DI SANITA

TERVEYDEN JA HYVINVOINNIN LAITOS

INSTITUTUL NATIONAL DE SANATATE PUBLICA

HELSEDIREKTORATET

THE MINISTRY OF HEALTH OF THE REPUBLIC OF POLAND

SCIENSANO

NACIONALNI INSTITUT ZA JAVNO ZDRAVJE

GESUNDHEIT OSTERREICH GMBH

Ministry for Health - Government of Malta

ROBERT KOCH-INSTITUT

Ministry of Health of the Republic of Cyprus

INSTITUTO DE SALUD CARLOS III

WELSH GOVERNMENT

Industry:

Pharmaceutical & Medical

Status:

Closed

Timeline

Published:

28 Feb 2018

Deadline:

30 May 2021

Value:

4999631.35

Contacts

Description

https://api.tech.ec.europa.eu/search-api/prod/rest/document/31061266801553?apiKey=SEDIA_NONH2020_PROD

InfAct (Information for Action) is a JA on health information (HI). HI is essential to build up country specific and cross-country knowledge. HI is the basis to inform national health policies, to steer population health investment decisions, to assess the effectiveness of different approaches to enhance population health through promotion, prevention, treatments and care. Timely, up-to-date HI is also vital in framing EU wide programs and policies. The major outcome expected of the JA is a sustainable solid infrastructure on EU HI through improving the availability of comparable, robust and policy-relevant health status data and health system performance information. Through country collaboration, the JA streamlines HI activities, reduces the data collection burden and works for a sustainable and robust data collection in Europe that facilitates and supports country knowledge, health research and policy making. The JA gives attention to: • develop the business case and roadmap for implementation of the European Research Infrastructure Consortium on Health Information for Research and Evidence-based Policy o governance structures, o national HI consortia and domain specific HI research networks • assess HI systems (HIS) in MS and regions • develop a roadmap for training in HI with the objective to tackle HI inequality through Europe • standardize HI instruments, tools and methods • strengthen the HI efficiency for public health policy through new ways of using health and non-health data sources • enhance the introduction of the interoperability of health data sources • enhance the translation of HI into public policy The JA watches for the sustainability of all actions taken by the JA. Coordination, dialogue and interaction with the Commission Expert Groups on HI and on HSPA, Eurostat, DG Research and other relevant DGs, international organization (WHO, OECD) reinforce further the sustainability of the JAs’ work and outcomes.

Featured tenders